You are currently viewing the summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Summary
European countries are embroiled in a debate over how to redo rules for clinical trials, an effort to replace a controversial 12-year-old directive that critics say bound human research studies in red tape. But preserving stringent patient protections without tipping into excessive bureaucracy—and getting 27 countries to agree—is no easy task.